Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;195(2):278-283.
doi: 10.1111/bjh.17637. Epub 2021 Jun 17.

Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience

Anna Maria Testi #  1 , Sara Mohamed #  1 , Daniela Diverio  1 , Alfonso Piciocchi  2 , Giuseppe Menna  3 , Carmelo Rizzari  4 , Fabio Timeus  5 , Concetta Micalizzi  6 , Luca Lo Nigro  7 , Nicola Santoro  8 , Riccardo Masetti  9 , Maria Vittoria Micheletti  10 , Ottavio Ziino  11 , Daniela Onofrillo  12 , Saverio Ladogana  13 , Caterina Putti  14 , Paolo Pierani  15 , Valentina Arena  2 , Marco Zecca  16 , Robin Foà  1 , Franco Locatelli  17   18
Affiliations

Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience

Anna Maria Testi et al. Br J Haematol. 2021 Oct.
No abstract available

Keywords: acute promyelocytic leukaemia; adolescent children; relapsed/refractory disease; salvage treatment.

PubMed Disclaimer

References

    1. Testi AM, Biondi A, Lo Coco F, Moleti ML, Giona F, Vignetti M, et al. GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106(2):447-53.
    1. Testi AM, Pession A, Diverio D, Grimwade D, Gibson B, de Azevedo AC, et al. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood. 2018;132:405-12.
    1. Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, et al. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis of two consecutive trials in the European APL Group. J Clin Oncol. 2012;30:1641-6.
    1. Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data. J Clin Oncol. 2010;28:3866-71.
    1. Cicconi L, Platzbecker U, Avvisati G, Paoloni F, Thiede C, Vignetti M, et al. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial. Leukemia. 2020;34:914-8.

MeSH terms

LinkOut - more resources